Momenta Pharmaceuticals (MNTA) PT Raised to $22 at Stifel
Tweet Send to a Friend
Stifel raised its price target on Momenta Pharmaceuticals (NASDAQ: MNTA) to $22.00 (from $21.00) while maintaining a Buy rating.Analyst Alex ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
